Skip to main content
. 2021 Jun 28;72(2):148–156. doi: 10.2478/aiht-2021-72-3422

Table 8.

The effect of AV-153-Ca on Psma3, Psmb5, Psmc6 and Psma6 gene expression in the kidney and liver

AV-153-Ca (mg/kg) Kidney fold difference (SEM range) Liver fold difference (SEM range)
Psma3 Control 1.00 (0.97–1.03) 1.00 (0.95–1.05)
0.05 0.89 (0.76–1.03) 0.96 (0.94–0.99)
0.50 1.00 (0.92–1.09) 0.89 (0.81–0.97)
Psmb5 Control 1.00 (0.99–1.02) 1.00 (0.94–1.04)
0.05 0.62 (0.55–0.71)** 1.05 (1.03–1.08)
0.50 0.85 (0.75–0.95) 0.82 (0.71–0.95)
Psmc6 Control 1.00 (0.97–1.03) 1.00 (0.92–1.09)
0.05 0.85 (0.77–0.93) 0.89 (0.86–0.93)
0.50 0.90 (0.84–0.96) 0.96 (0.88–1.05)
Psma6 Control 1.00 (0.92–1.08) 1.00 (0.94–1.06)
0.05 1.03 (0.96–1.11) 0.87 (0.82–0.93)
0.50 0.98 (0.89–1.07) 1.35 (1.22–1.48)*

*P<0.05 and **P<0.01 compared to control